P.2.b.021 Gender differences in serotonin transporter availability in patients with major depressionK. Uebelhack; L. Franke; N. Herold; M. Plotkin; H. Amthauer; R. Uebelhack · 2008

Platelet SHT and bipolar depressed patientsL. Franke; R. Uebelhack; B. Müller-Oerlinghausen · 2000

Imaging of serotonin transporters and its blockade by citalopram in patients with major depression using a novel SPECT ligand [123I]-ADAMN. Herold; K. Uebelhack; L. Franke; H. Amthauer; L. Luedemann; H. Bruhn; R. Felix; R. Uebelhack; M. Plotkin · 2006

P.3.11 Cognitive function and psychomotor performance in schizophrenic patientsS. Borgwardt; L. Franke; R. Uebelhack · 2004

P02-14 Gender differences in [123I]-ADAM binding to serotonin transporters in patients with major depression before and after treatment with CitalopramK. Uebelhack; L. Franke; N. Herold; M. Plotkin; H. Amthauer; R. Uebelhack · 2009

P.1.174 Multidimensional assessment of suicidal patients. The relationship between biochemical, psychological and psychopathological factorsB. Ahrens; C. Schumann; H. Berzewski; A. Berghöfer; L. Franke; B. Müller-Oerlinghausen; R. Uebelhack · 1997

High platelet-5HT uptake activity is associated with a rapid response in depressed patients treated with amitriptylineL. Franke; H.-J. Schewe; R. Uebelhack; B. Müller-Oerlinghausen · 2002

P.1.094 Reduction of the brain 123I-ADAM binding isrelated to the plasma drug level in amitriptyline treated subjectsR. Uebelhack; L. Franke; M. Piotkin; H. Amthauer; R. Felix. · 2004